VOLLTEXTSUCHE
Pressearchiv
Chameleon Pharma Consulting
Pressemitteilung

Polpharma strategic moves to buys a Pharma company in Kazakhstan

(PM) Berlin, 24.11.2011 - Polpharma has board the controlling share in the Pharma production company Khimpharm in the Shymkent Region in Kazakhstan. And has committed themselves to the following:

• Over the next 4 years, the pharmaceutical company plans toinvest about $ 85 million in the upgradeof infrastructure, developing of technology and products standards of Khimpharm;

• Already this year, it is scheduled to begin the construction of a new production plant for pharmaceuticals;

• After the implementing of GMP Standards, Polpharma will transfer the full production of its own drugs for the Eastern Europe market to manufacturing plants in Shymkent.

Polpharma was founded in 1935 in Gdański and it is now a major Polish producer of medicine. The company’s products are present in almost 50 countries. The most important markets for Polpharma are those of Central and Eastern Europe, including Belarus, Ukraine, Kazakhstan, Azerbaijan and Uzbekistan. Approximately 60% of the international sales of drugs are generated today on the Russian market.
ANLAGEN
PRESSEKONTAKT
Chameleon Pharma Consulting
Herr Reiner Christensen
Am Tempelhofer Berg 6
10965 Berlin
+49-30-64825164
E-Mail senden
Homepage
ZUM AUTOR
ÜBER CHAMELEON PHARMA CONSULTING

Chameleon Pharma Consulting ist der Pharma Beratungsexperte für M & A, Sales & Marketing, Vertrieb, Regulatory, R & D in der Region GUS (Russland, Ukraine, Kasachstan, Usbekistan, Weißrussland etc.) und Ost Europa (Polen, ...
DRUCKEN| VERSENDEN | RSS-FEED |
SOCIAL WEB
PRESSEFACH
Chameleon Pharma Consulting
Am Tempelhofer Berg 6
10965 Berlin
zum Pressefach
Anzeige
PRESSEARCHIV
Anzeige
BUSINESS-SERVICES
© novo per motio KG